Genesys (GENESYS) | Financial Analysis & Statements
Genesys International Corporation Ltd. Small-cap Technology
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
708.7M
Gross Profit
361.6M
51.03%
Operating Income
140.7M
19.85%
Net Income
69.8M
9.84%
EPS (Diluted)
₹1.74
Balance Sheet Metrics
Total Assets
7.8B
Total Liabilities
2.2B
Shareholders Equity
5.6B
Debt to Equity
0.40
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Genesys Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3.1B | 2.0B | 1.8B | 1.2B | 795.6M |
| Cost of Goods Sold | 1.3B | 916.2M | 960.5M | 806.7M | 640.7M |
| Gross Profit | 1.8B | 1.1B | 850.7M | 358.4M | 154.9M |
| Gross Margin % | 56.9% | 53.8% | 47.0% | 30.8% | 19.5% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 91.7M | 72.5M | 81.6M | 37.0M | 30.0M |
| Other Operating Expenses | 129.7M | 82.2M | 104.7M | 62.4M | 109.1M |
| Total Operating Expenses | 221.4M | 154.7M | 186.3M | 99.4M | 139.1M |
| Operating Income | 910.7M | 388.6M | 215.6M | 92.4M | -180.5M |
| Operating Margin % | 29.3% | 19.6% | 11.9% | 7.9% | -22.7% |
| Non-Operating Items | |||||
| Interest Income | 19.2M | 8.8M | 3.8M | 3.1M | 1.6M |
| Interest Expense | 87.8M | 39.1M | 26.7M | 24.8M | 38.9M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 826.8M | 371.8M | 250.0M | -358.7M | -544.4M |
| Income Tax | 265.7M | 155.6M | 100.6M | 38.2M | -26.6M |
| Effective Tax Rate % | 32.1% | 41.9% | 40.3% | 0.0% | 0.0% |
| Net Income | 561.0M | 216.1M | 149.3M | -396.9M | -517.9M |
| Net Margin % | 18.0% | 10.9% | 8.2% | -34.1% | -65.1% |
| Key Metrics | |||||
| EBITDA | 1.5B | 843.1M | 627.9M | 307.2M | 6.1M |
| EPS (Basic) | ₹14.17 | ₹5.78 | ₹5.44 | ₹4.28 | ₹-13.77 |
| EPS (Diluted) | ₹14.06 | ₹5.74 | ₹5.29 | ₹4.13 | ₹-13.77 |
| Basic Shares Outstanding | 39663880 | 38160656 | 35147151 | 31247559 | 31177186 |
| Diluted Shares Outstanding | 39663880 | 38160656 | 35147151 | 31247559 | 31177186 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Genesys Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 33.4M | 232.7M | 125.6M | 213.8M | 13.8M |
| Short-term Investments | 3.9M | 3.9M | 515.1M | 61.9M | 81.7M |
| Accounts Receivable | 2.2B | 1.4B | 832.2M | 491.5M | 323.0M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 87.2M | 113.3M | 130.0M | 91.7M | 55.5M |
| Total Current Assets | 4.6B | 3.3B | 2.4B | 1.3B | 752.7M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 825.1M | 816.6M | 619.5M | 416.1M | 398.9M |
| Goodwill | 2.1B | 1.9B | 1.6B | 1.2B | 2.0B |
| Intangible Assets | 2.1B | 1.9B | 1.6B | 1.2B | 1.3B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 45.2M | 38.6M | -1.0K | 2.4M | 11.7M |
| Total Non-Current Assets | 3.2B | 3.0B | 2.6B | 1.9B | 2.3B |
| Total Assets | 7.8B | 6.3B | 5.1B | 3.2B | 3.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 370.5M | 296.5M | 222.3M | 239.8M | 129.8M |
| Short-term Debt | 999.0M | 323.4M | 175.0M | 223.7M | 84.8M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 76.4M | 95.1M | 30.7M | 26.2M | 15.0M |
| Total Current Liabilities | 1.9B | 1.1B | 690.8M | 730.5M | 367.4M |
| Non-Current Liabilities | |||||
| Long-term Debt | 222.6M | 271.8M | 218.1M | 41.3M | 51.3M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | 40.0K |
| Total Non-Current Liabilities | 317.2M | 349.7M | 290.6M | 101.0M | 124.2M |
| Total Liabilities | 2.2B | 1.4B | 981.3M | 831.5M | 491.6M |
| Equity | |||||
| Common Stock | 199.0M | 197.7M | 188.8M | 156.8M | 156.1M |
| Retained Earnings | 1.3B | 723.7M | 595.9M | 833.1M | 814.8M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 5.6B | 4.9B | 4.1B | 2.4B | 2.5B |
| Key Metrics | |||||
| Total Debt | 1.2B | 595.2M | 393.2M | 265.0M | 136.1M |
| Working Capital | 2.7B | 2.2B | 1.7B | 549.8M | 385.3M |
Balance Sheet Composition
Genesys Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 826.8M | 371.8M | 250.0M | -358.7M | -544.4M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 29.7M | 31.6M | 26.9M | 14.2M | - |
| Working Capital Changes | -2.0B | -751.4M | -914.7M | -95.0M | 173.8M |
| Operating Cash Flow | -1.1B | -327.1M | -696.4M | -491.3M | -444.0M |
| Investing Activities | |||||
| Capital Expenditures | -433.7M | -732.9M | -851.9M | -83.6M | -77.8M |
| Acquisitions | - | 0 | -532.6M | 0 | - |
| Investment Purchases | 0 | -1.3B | -1.8B | -386.1M | -512.3M |
| Investment Sales | 351.8M | 1.3B | 1.4B | 413.3M | 483.1M |
| Investing Cash Flow | -81.9M | -702.6M | -1.8B | -50.0M | -107.0M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 28.2M | 161.2M | 236.0M | - | - |
| Debt Repayment | -97.0M | -72.3M | -26.0M | - | - |
| Financing Cash Flow | 631.2M | 780.0M | 2.2B | 164.6M | -41.0M |
| Free Cash Flow | -1.1B | -645.8M | -1.3B | -50.2M | 95.0M |
| Net Change in Cash | -517.4M | -249.8M | -226.6M | -376.6M | -592.0M |
Cash Flow Trend
Genesys Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
27.56
Forward P/E
19.54
Price to Book
1.61
Price to Sales
3.49
PEG Ratio
-0.29
Profitability Ratios
Profit Margin
12.32%
Operating Margin
-1.40%
Return on Equity
10.09%
Return on Assets
7.23%
Financial Health
Current Ratio
2.86
Debt to Equity
21.42
Beta
-0.59
Per Share Data
EPS (TTM)
₹9.64
Book Value per Share
₹164.56
Revenue per Share
₹77.40
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| GENESYS | 11.7B | 27.56 | 1.61 | 10.09% | 12.32% | 21.42 |
| Tata Elxsi | 261.2B | 43.23 | 10.06 | 27.45% | 15.68% | 5.34 |
| KFin Technologies | 172.0B | 49.62 | 11.73 | 23.63% | 27.73% | 3.24 |
| Emudhra | 41.1B | 40.65 | 5.08 | 11.33% | 15.68% | 2.02 |
| Technvision Ventures | 35.1B | 1,000.00 | 330.96 | 0.70% | 1.50% | 87.09 |
| Network People | 25.4B | 67.60 | 5.72 | 43.26% | 21.76% | 1.64 |
Financial data is updated regularly. All figures are in the company's reporting currency.





